Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2022 Filed Jun 30, 2022 00:01 UTC |
DAmour KevinChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-024524 · form4.xml · nonDerivative · entry 1 DAmour Kevin · CIK 0001870486 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock. Read SEC document |
| June 21, 2022 Filed Jun 24, 2022 00:31 UTC |
Gurrola Sandra MVice President of Finance
|
Exercise / conversionRestricted Stock Units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-023928 · form4.xml · derivative · entry 3 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock. F2 · derivative.exercise_date: On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. Read SEC document |
| June 21, 2022 Filed Jun 24, 2022 00:31 UTC |
Gurrola Sandra MVice President of Finance
|
Tax withholdingCommon Stock | 3,586 | $0.48 | $1,708.73 |
DisclosureSEC source: 0001140361-22-023928 · form4.xml · nonDerivative · entry 2 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,367 Read SEC document |
| June 21, 2022 Filed Jun 24, 2022 00:31 UTC |
Gurrola Sandra MVice President of Finance
|
Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-023928 · form4.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:01 UTC |
Jackson Andrew C.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 664,800 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001140361-22-022025 · form4.xml · derivative · entry 1 Jackson Andrew C. · CIK 0001636738 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 664,800 Underlying: Common Stock, par value $0.005 per share · 664,800 shares Expires 2032-06-03 F1 · derivative.exercise_date: The stock option vests and becomes exercisable over four years (subject to continued service), with 25% of the shares vesting on May 31, 2023 and the remaining shares vesting in 36 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 01:34 UTC |
Gurrola Sandra MVice President of Finance
|
GrantStock Option (Right to buy) · Derivative | 114,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009663 · form4.xml · derivative · entry 1 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,500 Underlying: Common Stock · 114,500 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 01:34 UTC |
Federoff Howard J.Director · CEO & President
|
GrantStock Option (Right to buy) · Derivative | 413,700 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009662 · form4.xml · derivative · entry 1 Federoff Howard J. · CIK 0001857261 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,700 Underlying: Common Stock · 413,700 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 01:34 UTC |
DAmour KevinChief Scientific Officer
|
GrantStock Option (Right to buy) · Derivative | 138,400 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009664 · form4.xml · derivative · entry 1 DAmour Kevin · CIK 0001870486 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,400 Underlying: Common Stock · 138,400 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 01:34 UTC |
Sial JayChief Administration Officer
|
GrantStock Option (Right to buy) · Derivative | 117,200 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009661 · form4.xml · derivative · entry 1 Sial Jay · CIK 0001873057 · Chief Administration Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,200 Underlying: Common Stock · 117,200 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 16, 2022 01:34 UTC |
Sidhu RogerChief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 142,100 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009660 · form4.xml · derivative · entry 1 Sidhu Roger · CIK 0001884115 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,100 Underlying: Common Stock · 142,100 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 11, 2022 Filed Mar 18, 2022 01:00 UTC Amendment |
Gurrola Sandra MVice President of Finance
|
GrantStock Option (Right to buy) · Derivative | 114,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009983 · form4.xml · derivative · entry 1 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,500 Underlying: Common Stock · 114,500 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. Read SEC document |
| March 11, 2022 Filed Mar 18, 2022 01:00 UTC Amendment |
DAmour KevinChief Scientific Officer
|
GrantStock Option (Right to buy) · Derivative | 138,400 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009984 · form4.xml · derivative · entry 1 DAmour Kevin · CIK 0001870486 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,400 Underlying: Common Stock · 138,400 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. Read SEC document |
| March 11, 2022 Filed Mar 18, 2022 01:00 UTC Amendment |
Federoff Howard J.Director · CEO & President
|
GrantStock Option (Right to buy) · Derivative | 413,700 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009982 · form4.xml · derivative · entry 1 Federoff Howard J. · CIK 0001857261 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,700 Underlying: Common Stock · 413,700 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. Read SEC document |
| March 11, 2022 Filed Mar 18, 2022 01:00 UTC Amendment |
Sial JayChief Administration Officer
|
GrantStock Option (Right to buy) · Derivative | 117,200 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009981 · form4.xml · derivative · entry 1 Sial Jay · CIK 0001873057 · Chief Administration Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,200 Underlying: Common Stock · 117,200 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. Read SEC document |
| March 11, 2022 Filed Mar 18, 2022 01:00 UTC Amendment |
Sidhu RogerChief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 142,100 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001140361-22-009980 · form4.xml · derivative · entry 1 Sidhu Roger · CIK 0001884115 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,100 Underlying: Common Stock · 142,100 shares Expires 2032-03-11 F1 · derivative.exercise_date: The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 02:46 UTC |
Redman Heather BDirector
|
GrantStock Option (right to buy) · Derivative | 67,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001140361-22-002078 · form4.xml · derivative · entry 1 Redman Heather B · CIK 0001887532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock, par value $0.005 per share · 67,000 shares Expires 2032-01-14 F1 · derivative.exercise_date: The stock option vests (subject to continued service) with respect to 22,336 shares of common stock on the first anniversary of the grant date and then in subsequent monthly installments of 1,861 shares of common stock through the three-year anniversary of the grant date. Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 02:46 UTC |
ENRIGHT ERIN S.Director
|
GrantStock Option (right to buy) · Derivative | 67,000 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001140361-22-002077 · form4.xml · derivative · entry 1 ENRIGHT ERIN S. · CIK 0001579347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock, par value $0.005 per share · 67,000 shares Expires 2032-01-14 F1 · derivative.exercise_date: The stock option vests (subject to continued service) with respect to 22,336 shares of common stock on the first anniversary of the grant date and then in subsequent monthly installments of 1,861 shares of common stock through the three-year anniversary of the grant date. Read SEC document |
| December 08, 2021 Filed Dec 11, 2021 02:00 UTC |
Mohr ErichDirector
|
GrantStock Option · Derivative | 67,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001140361-21-041285 · form4.xml · derivative · entry 1 Mohr Erich · CIK 0001298170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2031-12-07 F1 · derivative.exercise_date: A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date. Read SEC document |
| December 08, 2021 Filed Dec 11, 2021 02:00 UTC |
Greenwood LubaDirector
|
GrantStock Option · Derivative | 67,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001140361-21-041287 · form4.xml · derivative · entry 1 Greenwood Luba · CIK 0001853815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2031-12-07 F1 · derivative.exercise_date: A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date. Read SEC document |
| December 08, 2021 Filed Dec 11, 2021 02:00 UTC |
Cherington CharlesDirector
|
GrantStock Option · Derivative | 67,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001140361-21-041286 · form4.xml · derivative · entry 2 Cherington Charles · CIK 0001448698 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2031-12-07 F2 · derivative.exercise_date: A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date. Read SEC document |
| December 08, 2021 Filed Dec 11, 2021 02:00 UTC |
LANGER DENNISDirector
|
GrantStock Option · Derivative | 67,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001140361-21-041284 · form4.xml · derivative · entry 1 LANGER DENNIS · CIK 0001274225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2031-12-07 F1 · derivative.exercise_date: A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:57 UTC |
Sidhu RogerSee Remarks
|
GrantRestricted Stock Unit · Derivative | 80,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-032105 · form4.xml · derivative · entry 2 Sidhu Roger · CIK 0001884115 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,650 Underlying: Common Stock · 80,650 shares Expires 2031-09-20 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: The RSU Grant vests and becomes exercisable in four equal installments on September 20 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Dr. Sidhu's Executive Employment Agreement, effective September 20, 2021), subject to continued service through each vesting date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:57 UTC |
Sidhu RogerSee Remarks
|
GrantStock Option · Derivative | 161,300 | $0.00 Strike: $9.96 | $0.00 |
DisclosureSEC source: 0001140361-21-032105 · form4.xml · derivative · entry 1 Sidhu Roger · CIK 0001884115 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,300 Underlying: Common Stock · 161,300 shares Expires 2031-09-20 F1 · derivative.exercise_date: The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on September 20, 2022, and 1/36 of the remaining shares covered thereby vesting on the twentieth day of each calendar month from October 2022 through September 20, 2025, subject to continued service through each vesting date. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 01:30 UTC |
Sial JaySee Remarks
|
GrantRestricted Stock Unit · Derivative | 35,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-024855 · form4.xml · derivative · entry 2 Sial Jay · CIK 0001873057 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,700 Underlying: Common Stock · 35,700 shares Expires 2031-07-15 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: The RSU Grant vests and becomes exercisable in four equal installments on July 15 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Mr. Sial's Executive Employment Agreement, dated as of July 6, 2021 and effective July 15, 2021), subject to continued service through each vesting date. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 01:30 UTC |
Sial JaySee Remarks
|
GrantStock Option · Derivative | 71,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001140361-21-024855 · form4.xml · derivative · entry 1 Sial Jay · CIK 0001873057 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,000 Underlying: Common Stock · 71,000 shares Expires 2031-07-15 F1 · derivative.exercise_date: The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on July 15, 2022, and 1/36 of the remaining shares covered thereby vesting on the 15th day of each calendar month from August 2022 through July 15, 2025, subject to continued service through each vesting date. Read SEC document |
| July 14, 2021 Filed Aug 20, 2021 17:38 UTC |
DENNY GEORGE P III10% owner
|
PurchaseCommon Stock | 1 | $11.99 | $11.99 |
DisclosureSEC source: 0001062993-21-007818 · form4.xml · nonDerivative · entry 4 DENNY GEORGE P III · CIK 0001234956 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3 Read SEC document |
| July 09, 2021 Filed Aug 20, 2021 17:38 UTC |
DENNY GEORGE P III10% owner
|
PurchaseCommon Stock | 1 | $14.11 | $14.11 |
DisclosureSEC source: 0001062993-21-007818 · form4.xml · nonDerivative · entry 3 DENNY GEORGE P III · CIK 0001234956 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2 Read SEC document |
| July 08, 2021 Filed Aug 20, 2021 17:38 UTC |
DENNY GEORGE P III10% owner
|
PurchaseCommon Stock | 1 | $14.35 | $14.35 |
DisclosureSEC source: 0001062993-21-007818 · form4.xml · nonDerivative · entry 2 DENNY GEORGE P III · CIK 0001234956 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1 Read SEC document |
| July 06, 2021 Filed Aug 20, 2021 17:38 UTC |
DENNY GEORGE P III10% owner
|
SaleCommon Stock | 75,000 | $16.06 | $1,204,687.50 |
DisclosureSEC source: 0001062993-21-007818 · form4.xml · nonDerivative · entry 1 DENNY GEORGE P III · CIK 0001234956 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Denny Family Partners II, LLC Disclosed balance after: 4,775,117 F1 · kind: The sale by Denny Family Partners II, LLC of BTX Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 3 shares, with the purchase of 3 shares of BTX Common Stock by the reporting person's spouse, also reported herein. The reporting person has agreed to pay to BTX, upon settlement of the sale, $8.78, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.41, inclusive. The reporting person undertakes to provide to Brooklyn ImmunoTherapeutics, Inc., any security holder of Brooklyn ImmunoTherapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2. F3 · ownership.nature: The reporting person disclaims beneficial ownership of the shares held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| June 28, 2021 Filed Jul 1, 2021 01:34 UTC |
DAmour KevinSee Remarks
|
GrantRestricted Stock Unit · Derivative | 70,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-023007 · form4.xml · derivative · entry 2 DAmour Kevin · CIK 0001870486 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,290 Underlying: Common Stock · 70,290 shares Expires 2031-06-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: The Restricted Stock Unit vests and becomes exercisable in four equal installments on June 28 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Dr. D'Amour's Executive Employment Agreement, dated as of June 5, 2021 and effective as of June 28, 2021), subject to continued service through each vesting date. Read SEC document |
| June 28, 2021 Filed Jul 1, 2021 01:34 UTC |
DAmour KevinSee Remarks
|
GrantStock Option · Derivative | 140,580 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001140361-21-023007 · form4.xml · derivative · entry 1 DAmour Kevin · CIK 0001870486 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,580 Underlying: Common Stock · 140,580 shares Expires 2031-06-28 F1 · derivative.exercise_date: The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on June 28, 2022, and 1/36 of the remaining shares covered thereby vesting on the 28th day of each calendar month from July 28, 2022 through June 28, 2025, subject to continued service through each vesting date. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 22:01 UTC |
Gurrola Sandra MVice President of Finance
|
GrantRestricted Stock Unit · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-021928 · form4.xml · derivative · entry 1 Gurrola Sandra M · CIK 0001618457 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date. F2 · derivative.expiration_date: The option vests and becomes exercisable in four equal installments on June 21 of each of 2022, 2023, 2024 and 2025, provided they shall vest in full immediately prior to a Change in Control (as defined in Ms. Gurrola's Executive Employment Agreement, dated as of June 16, 2021 and effective as of June 21, 2021), subject to continued service through each vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:00 UTC |
Cherington CharlesDirector · 10% owner
|
SaleCommon Stock | 2,000 | $16.30 | $32,594.80 |
DisclosureSEC source: 0001140361-21-021772 · form4.xml · nonDerivative · entry 3 Cherington Charles · CIK 0001448698 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,894,101 F3 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.35, inclusive. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 22:00 UTC |
Cherington CharlesDirector · 10% owner
|
SaleCommon Stock | 198,000 | $15.74 | $3,117,213.00 |
DisclosureSEC source: 0001140361-21-021772 · form4.xml · nonDerivative · entry 2 Cherington Charles · CIK 0001448698 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,896,101 F2 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $16.24, inclusive. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 22:00 UTC |
Cherington CharlesDirector · 10% owner
|
SaleCommon Stock | 200,000 | $15.73 | $3,146,760.00 |
DisclosureSEC source: 0001140361-21-021772 · form4.xml · nonDerivative · entry 1 Cherington Charles · CIK 0001448698 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,094,101 F1 · price: The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.53 to $16.11, inclusive. Read SEC document |
| June 01, 2021 Filed Dec 11, 2021 02:00 UTC |
Cherington CharlesDirector
|
OtherCommon Stock | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-041286 · form4.xml · nonDerivative · entry 1 Cherington Charles · CIK 0001448698 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,894,193 F1 · kind: Represents a stock dividend declared on shares of the Issuer's Series A Preferred Stock. F1 · price: Represents a stock dividend declared on shares of the Issuer's Series A Preferred Stock. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 00:16 UTC |
Federoff Howard J.Director · See Remarks
|
GrantStock Option · Derivative | 597,253 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001140361-21-013551 · form4.xml · derivative · entry 2 Federoff Howard J. · CIK 0001857261 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,253 Underlying: Common Stock · 597,253 shares Expires 2031-04-15 F2 · derivative.exercise_date: The option vests and becomes exercisable in full upon the occurrence of the first approval by the Food and Drug Administration of an investigational new drug application in connection with that certain license among the Issuer, Factor Biosciences Therapeutics Limited and Novellus Therapeutics Limited, subject to continued service through such vesting date. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 00:16 UTC |
Federoff Howard J.Director · See Remarks
|
GrantStock Option · Derivative | 2,627,915 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001140361-21-013551 · form4.xml · derivative · entry 1 Federoff Howard J. · CIK 0001857261 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,627,915 Underlying: Common Stock · 2,627,915 shares Expires 2031-04-15 F1 · derivative.exercise_date: The option vests and becomes exercisable over four years, with 656,979 shares vesting on April 16, 2022, 54,748 shares vesting on the sixteenth day of each month from May 2022 through March 2025, and the remaining 54,756 shares vesting on April 16, 2025, subject to continued service through each vesting date. Read SEC document |
| March 24, 2021 Filed Mar 27, 2021 01:54 UTC |
Wolff AllenDirector · Former Director and CEO
|
Tax withholdingCommon Stock | 9,944 | $2.67 | $26,550.48 |
DisclosureSEC source: 0001140361-21-010365 · form4.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · Former Director and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,520 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the "Merger") contemplated by the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC. The number of shares withheld was determinable on March 24, 2021. No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the "Merger") contemplated by the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC. The number of shares withheld was determinable on March 24, 2021. No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger. Read SEC document |
| March 24, 2021 Filed Mar 27, 2021 01:53 UTC |
Gurrola Sandra MFormer SVP of Finance
|
Tax withholdingCommon Stock | 6,094 | $2.67 | $16,270.98 |
DisclosureSEC source: 0001140361-21-010363 · form4.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · Former SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,617 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the "Merger") contemplated by the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC. The number of shares withheld was determinable on March 24, 2021. No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 23:00 UTC |
Wolff AllenDirector · CEO
|
Tax withholdingCommon Stock | 207 | $3.53 | $730.71 |
DisclosureSEC source: 0001493152-21-006564 · ownership.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,464 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 23:00 UTC |
Gurrola Sandra MSVP of Finance
|
Tax withholdingCommon Stock | 116 | $3.53 | $409.48 |
DisclosureSEC source: 0001493152-21-006563 · ownership.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,711 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 22:30 UTC |
Gurrola Sandra MSVP of Finance
|
Tax withholdingCommon Stock | 115 | $4.81 | $553.15 |
DisclosureSEC source: 0001493152-21-004520 · ownership.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,827 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 22:30 UTC |
Wolff AllenDirector · CEO
|
Tax withholdingCommon Stock | 207 | $4.81 | $995.67 |
DisclosureSEC source: 0001493152-21-004521 · ownership.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,671 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 22:30 UTC |
Gurrola Sandra MSVP of Finance
|
Tax withholdingCommon Stock | 1,400 | $2.55 | $3,570.00 |
DisclosureSEC source: 0001493152-21-001453 · ownership.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,942 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 22:30 UTC |
Wolff AllenDirector · CEO
|
Tax withholdingCommon Stock | 2,987 | $2.55 | $7,616.85 |
DisclosureSEC source: 0001493152-21-001452 · ownership.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,878 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction. Read SEC document |
| December 19, 2020 Filed Dec 22, 2020 01:00 UTC |
Gurrola Sandra MSVP of Finance
|
Tax withholdingCommon Stock | 100 | $2.17 | $217.00 |
DisclosureSEC source: 0001493152-20-024074 · ownership.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,342 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction. Read SEC document |
| December 19, 2020 Filed Dec 22, 2020 01:00 UTC |
Wolff AllenDirector · CEO
|
Tax withholdingCommon Stock | 170 | $2.17 | $368.90 |
DisclosureSEC source: 0001493152-20-024073 · ownership.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,865 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC |
Wolff AllenDirector · CEO
|
Tax withholdingCommon Stock | 170 | $1.88 | $319.60 |
DisclosureSEC source: 0001493152-20-022151 · ownership.xml · nonDerivative · entry 1 Wolff Allen · CIK 0001628529 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,035 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2020. No shares were sold in connection with this transaction. F1 · price: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2020. No shares were sold in connection with this transaction. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC |
Gurrola Sandra MSVP of Finance
|
Tax withholdingCommon Stock | 98 | $1.88 | $184.24 |
DisclosureSEC source: 0001493152-20-022147 · ownership.xml · nonDerivative · entry 1 Gurrola Sandra M · CIK 0001618457 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,442 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2020. No shares were sold in connection with this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.